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Abstract
Birth asphyxia and the resulting neonatal encephalopathy are a significant cause of
mortality  and long-term morbidity in children.  Hypothermia is  currently the only
neuroprotective treatment to have been clinically tested in large trials to prevent the
development of brain injury in some term asphyxiated newborns. Most of the asphyxi‐
ated newborns treated with hypothermia are intubated at birth as per resuscitation
measures and remain on mechanical ventilation during some part of the hypothermia
treatment or during the whole length of the treatment. They also may present with
oxygenation problems. Very often, they present with hypocapnia that can be worsened
with the use of mechanical ventilation during the first days of life. When taking care of
these newborns, a few important points should be remembered about the impact of
asphyxia and therapeutic hypothermia on oxygenation and ventilation. In this article, we
review some of the physiopathology behind neonatal encephalopathy and the implica‐
tions of brain cooling from a respiratory point of view. Strategies to optimize oxygena‐
tion and ventilation for these newborns, as well as to prevent further brain injury, are also
discussed based on a current literature review.
Keywords: brain, hypocapnia, neonatal encephalopathy, persistent pulmonary hyper‐
tension, ventilation
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
1. Introduction
Birth asphyxia and the resulting neonatal encephalopathy are significant causes of infant
morbidity and mortality. Every year, three to five newborns per 1000 live births suffer from
birth asphyxia and have an increased risk to die or to develop long-term neurodevelopmental
sequelae [1, 2]. The sequelae may range from mild traits such as language impairments, attention
deficits, and hyperactivity to more severe traits such as cerebral palsy, global developmental
delay, and epilepsy [3].
Brain injury secondary to birth asphyxia and neonatal encephalopathy is a dynamic two-step
process. Initially, the asphyxial insult leads to decreased blood flow to the brain (primary
lesions), and this oxygen and blood deprivation around the time of birth may cause direct
neuronal cell injury and cell death (necrosis) within minutes [4]. Then, as the blood flow is
restored in an injured brain, a cascade of secondary pathways is initiated within the first hours
and days of life that can lead to further worsening of neuronal cell injury and cell death
(apoptosis) (“reperfusion injury”). Several mechanisms have been involved in these reperfu‐
sion injuries, that is, excitotoxicity from glutamate and aspartate release, disruption of calcium
homeostasis, generation of oxygen-free radicals, and inflammation [2].
In the past, asphyxiated newborns were managed with supportive care only (avoidance of
hypotension, avoidance of hypoglycemia, correction of blood gas parameters, and seizure
control), with the goal to maintain homeostasis to limit brain injury [5]. In recent years, a
number of large trials have demonstrated the efficacy of therapeutic hypothermia for the
treatment of neonatal encephalopathy [6–12]. Therapeutic hypothermia is currently the only
neuroprotective treatment demonstrated to be effective for preventing the development of
brain injury in some term asphyxiated newborns by preventing reperfusion injuries [8] and
for decreasing the risk of death and disability [1, 13, 14]. Therapeutic hypothermia involves
systemic or selective head cooling of the asphyxiated newborns to an esophageal temperature
of 33.5°C. Based on animal studies, the treatment has been shown to be efficient when started
within 6 hours of life and continued for 72 hours, followed by progressive rewarming [6–12].
The exact therapeutic window in humans is yet to be determined.
Despite hypothermia treatment, a significant number of asphyxiated newborns still develop
brain injury, and maintenance of homeostasis within the first hours and days of life is of the
utmost importance.
2. Impact of birth asphyxia on oxygenation and ventilation
Brain oxygenation occurs normally through the glycolytic pathway where glucose is converted
to pyruvate. This step produces the formation of the acetyl coenzyme, which enters the Krebs
cycle to generate energy in the form of adenosine triphosphate through mitochondrial
oxidative phosphorylation [15]. Thus, oxygen delivery to the brain cells is critical for oxidative
phosphorylation to occur and for the cell to produce energy. In contrast, excessive oxygen
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delivery to this powerful cellular machinery will result in the generation of oxygen-free
radicals leading to hyperoxia-related brain and lung injury [16]. The delivery of oxygen to the
different organs, especially the brain, requires several key steps. First, oxygen is delivered from
the air to the lungs. The second step occurs in the lungs at the alveolar level where the delivered
oxygen is exchanged with tissue-produced carbon dioxide; this step requires adequately
functioning alveoli and pulmonary vessels around these alveoli. The third step requires an
adequate circulating blood flow generated by the heart to deliver the oxygen to the tissues,
but also an adequate cerebral perfusion for oxygen delivery to occur in the brain. The fourth
step is the extraction of the hemoglobin-bound oxygen by the tissues and its delivery to the
cells.
Birth asphyxia affects the oxygenation process through several mechanisms. At the cellular
level, the asphyxial event deprives cells from oxygen, and thus, pyruvate is converted to lactate
through the lactate dehydrogenase enzyme. In addition, this anaerobic condition blocks the
oxidative phosphorylation in the mitochondria, which leads to energy production failure, since
adenosine triphosphate production is reduced [15]. In the lungs, asphyxia increases pulmo‐
nary vascular resistance, and thus the risk of persistent pulmonary hypertension, and therefore
contributes to oxygenation failure, since persistent pulmonary hypertension often leads to a
right-to-left shunting of deoxygenated blood, and thus a decreased delivery of oxygen to the
brain [17]. This right-to-left shunting could be either intracardiac through the patent foramen
ovale or through the ductus arteriosus, or intrapulmonary shunting. Also, high pulmonary
vascular resistance may impair oxygenation in the absence of shunting by causing right
ventricular dysfunction. Asphyxia also has a direct negative impact on cardiac function [18],
and this cardiac dysfunction may contribute to oxygenation failure, since an adequate cardiac
output is important for oxygen delivery to all tissues, particularly the brain. An impairment
of the oxygen process has the potential to worsen brain injury in asphyxiated newborns.
Birth asphyxia leads to metabolic acidosis, mainly because the cells switch to an anaerobic
metabolism as oxygen gets depleted, which leads to lactate accumulation [19]. This metabolic
acidosis may lead to hyperventilation, hypocapnia, and the development of a respiratory
alkalosis. Hypocapnia has been shown to exacerbate brain injury and lead to negative
outcomes. Hypocapnia alters pH, reduces cerebral blood flow (through vasoconstriction and
a release of vasoactive factors), alters potassium channels, and affects calcium homeostasis, all
of which contribute to further damaging the brain. Hypocapnia has been associated with
periventricular leukomalacia, intraventricular hemorrhage, cerebral palsy, cognition devel‐
opmental disorder, and auditory deficits [20]. Thus, it may also worsen brain injury in
asphyxiated newborns.
Clinical manifestations of neonatal encephalopathy include an initially altered level of
consciousness, tone and reflexes, and seizures may happen [9, 21]. Respiratory difficulties are
very often associated with the initial neonatal encephalopathy [21]. Most asphyxiated new‐
borns are intubated at birth as per resuscitation measures and remain on mechanical ventila‐
tion during some part of the hypothermia treatment or during the whole length of the
treatment [22].
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3. Impact of hypothermia on oxygenation and ventilation
Mild hypothermia achieves neuroprotection mainly by decreasing metabolic demand and
minimizing secondary energy failure. A reduction of 2–4°C of the body temperature of
asphyxiated newborns can decrease their rate of cell death, delay metabolic changes, and even
delay secondary brain injury [23]. The metabolic rate decreases by 5–8% with every 1°C
reduction in core temperature, which in turn reduces glucose and oxygen utilization, and
therefore mitigates energy failure following the initial asphyxial event [24].
Overall, hypothermia has a direct and favorable effect on oxygenation parameters (Table 1).
Hypothermia shifts the oxygen-dissociation curve to the left, and thus, a lower partial pressure
of oxygen is needed to achieve the same level of hemoglobin saturation. This left shift prevents
some of the oxygen release to the tissues, which should be considered an appropriate phys‐
iological adaptation, since hypothermia also decreases the demand for oxygen. Although
hypothermia has been suspected to worsen the existing pulmonary hypertension caused by
asphyxia [25], larger randomized studies of asphyxiated newborns that have tested hypother‐
mia as a treatment did not report an increased incidence of persistent pulmonary hypertension
[1, 26]. In addition, hypothermia also may have an impact on lung mechanisms [27]. Asphyxi‐
ated newborns treated with hypothermia tend to have an increased compliance and a de‐
creased mean airway pressure, and these changes tend to reverse during the rewarming
process [27], and may thus predispose the newborn to a worsening of the underlying persistent
pulmonary hypertension during that phase of treatment [27]. Further impairment of persistent
pulmonary hypertension, and thus of oxygenation, has the potential to worsen the brain injury
of asphyxiated newborns treated with hypothermia.
Parameters Changes during hypothermia treatment Management Strategies
Oxygen (FiO2 and pO2) Lower temperature shifts the oxygen-dissociation curve to the left. Lower
pO2 are thus needed to achieve samelevel of hemoglobin saturation
Avoid hyperoxia (lower PO2 may beneeded to achieve same saturation)
Mean airway pressure
(MAP)
Lower temperature increases
lung compliance and decreases mean airway
pressure
Optimize lung recruitment and avoid
overdistension (lower MAP may be
needed). Carefully monitor changes in
lung compliance during rewarming
Ventilatory rate Lower temperature decreases metabolic
rate, and thus CO2 production
Avoid hyperventilation by adjusting
ventilatory settings
Pulmonary pressure Lower temperature may worsen
persistent pulmonary hypertension (?)
Use O2 and NO as needed to avoid furtherhypoxia. Maintain adequate systemic blood
pressure. ECMO to be considered when
optimized treatment fails. Avoid hyperoxia
Blood gas analysis Lower temperature decreases pCO2and increases pH
“pH-stat” strategy (correction of pH and
pCO2 to the body temperature) suggestedas the most cautious approach
Abbreviations: ECMO, extracorporeal membrane oxygenation; FiO2, fraction of inspired oxygen; NO, nitric oxide;
pCO2, partial pressure of carbon dioxide; pO2, partial pressure of oxygen.
Table 1. Ventilation in asphyxiated newborns treated with hypothermia.
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Another important factor to take into account is the variations in oxygen utilization and
demand that occur during hypothermia treatment, in particular during the first few hours of
life. In a previous study on asphyxiated newborns treated with hypothermia, the regional
cerebral oxygen saturation measured by near-infrared spectroscopy (NIRS) increased from
day 1 to 2 of life in all newborns regardless of whether they did or did not develop brain injury.
However, newborns who later develop brain injury had higher regional cerebral oxygen
saturation, which may reflect either more severe neuronal injury, and thus less utilization of
oxygen by dead tissues, or the phenomenon of luxury perfusion that occurs when increased
brain perfusion exceeds the metabolic demand [28].
As previously mentioned, hypothermia decreases metabolic rate and therefore leads to a
decrease in carbon dioxide production. With respect to an asphyxiated newborn treated with
hypothermia, who is breathing spontaneously, this means that any drop in the partial pressure
of carbon dioxide (by a decrease in carbon dioxide production) will correlate with decreased
ventilation via chemoreceptor inhibitory input into the respiratory center, in an effort to
maintain a stable partial pressure of carbon dioxide. However, regarding an asphyxiated
newborn treated with hypothermia, who is intubated, a risk of hyperventilation and respira‐
tory alkalosis exits if the ventilator parameters are not adjusted to the decreased carbon dioxide
production [22]. Further worsening of the hypocapnia by hypothermia may further worsen
brain injury in asphyxiated newborns treated with hypothermia.
4. Evidence for best practices for ventilation in asphyxiated newborns
treated with hypothermia
Most asphyxiated newborns are intubated at birth as per resuscitation measures and remain
on mechanical ventilation during some part of the hypothermia treatment or during the whole
length of the treatment. Past studies have reported that the ventilatory management of
asphyxiated newborns treated with hypothermia is very complex [29], since it has to take into
account all the previously discussed issues. The adjustment of ventilator settings should be
closely fine-tuned to optimize oxygenation and limit hypocapnia in asphyxiated newborns
treated with hypothermia (Table 1).
Mechanical ventilation in asphyxiated newborns treated with hypothermia should aim for
optimal lung recruitment and avoidance of overdistension. Optimal lung recruitment should
decrease atelectasis, which may reduce the effective gas exchange area in the lungs and
contribute to the hypoxic pulmonary vasoconstriction [25]. In contrast, overdistension should
be avoided, since it may lead to systemic hypotension by decreasing venous return, exacerbate
persistent pulmonary hypertension, worsen the oxygen delivery, and thus decrease the organs’
perfusion, particularly the brain [30]. No evidence from randomized controlled trials has
suggested the superiority of high-frequency oscillatory ventilation over conventional me‐
chanical ventilation in near-term and term newborns [31]. In addition, no available studies
have explored which mode is the most suitable among the different possible modes of
mechanical ventilation for these newborns.
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After optimal lung recruitment, optimizing oxygenation consists mainly in limiting persistent
pulmonary hypertension. Wide variations in the management of persistent pulmonary
hypertension persist among neonatologists, which probably reflect the lack of an evidence-
based approach for the treatment of neonatal persistent pulmonary hypertension [32]. In
addition, the most optimal values for oxygenation parameters for asphyxiated newborns
during hypothermia treatment are currently not known and probably vary according to the
day of life, as has been demonstrated by the previously discussed variations in oxygen
utilization and demand that occur during hypothermia treatment. Increasing the fraction of
inspired oxygen has a known pulmonary vasodilator effect and should thus improve oxygen
delivery and decrease the risk of further brain injury. However, this increase in the fraction of
inspired oxygen should be carefully monitored, since hyperoxia or an excessive delivery of
oxygen relative to the demand may lead to a worsening of brain injury through the formation
of oxygen-free radicals that could at the same time worsen pulmonary hypertension [33].
Although current evidence does not support the early use of inhaled nitric oxide in preterm
infants, it has been shown to decrease the need for extracorporeal membrane oxygenation in
near-term and term infants with hypoxic respiratory failure [34]. Given the potential-added
beneficial effect on neuroprotection and the possible impact of persistent pulmonary
hypertension on brain injury, the use of nitric oxide should be considered early in the course
of treatment [35]. In addition, it is important to consider cardiopulmonary interactions and
optimize blood pressure in these newborns to limit the right-to-left shunting. As a last
treatment resort, extracorporeal membrane oxygenation should be considered to optimize
oxygenation and has been demonstrated to be feasible for asphyxiated newborns treated with
hypothermia [17]. Further studies are needed to determine the most optimal values for
oxygenation parameters and the best methods to reach them with respect to asphyxiated
newborns treated with hypothermia.
Limiting hypocapnia is the next important step. Several studies have highlighted the impor‐
tance of preventing hypocapnia in ventilated asphyxiated newborns during hypothermia [29,
36]. It remains to be established what has the worst impact on brain perfusion—a single
hypocapnic episode, cumulative hypocapnia, and/or fluctuations in the partial pressure of
carbon dioxide [29]. Moreover, it may be the combination of hypocapnia with hyperoxia that
could lead to more adverse outcomes [36]. Alternatively, hypercapnia also should be avoided,
since it has been shown to alter cerebral blood flow by causing cerebral vasodilatation and
impairing cerebral autoregulation [37]. Currently, conflicting evidence exists with respect to
the efficacy of permissive hypercapnia on brain protection. Although some studies have
argued that it helps to avoid ventilation-induced brain injury [20], a recent study on extremely
low-birth weight infants has found no significant decrease in lung injury nor mortality in
newborns managed with permissive hypercapnia [38]. Permissive hypercapnia has yet to be
further studied in asphyxiated newborns receiving therapeutic hypothermia. Further studies
that continuously monitor the partial pressure of carbon dioxide levels and quickly adjust the
ventilator settings would be necessary to improve the ventilatory management of these
newborns.
Respiratory Management of Newborns76
To monitor the changes in the partial pressure of carbon dioxide and pH during hypothermia
treatment and the adjustment of ventilatory settings, two strategies are available, depending
on whether the partial pressure of carbon dioxide and pH are corrected or not for temperature.
The “α-stat” strategy does not correct the partial pressure of carbon dioxide and pH for body
temperature; rather, it measures them at normal body temperature (37°C) as is usually done
for lab measurements of blood gas parameters if not specified otherwise. Alternatively, the
“pH-stat” strategy adjusts the partial pressure of carbon dioxide and pH values to the actual
body temperature of the newborn. At hypothermia temperature (33.5°C), the partial pressure
of carbon dioxide will decrease and pH will increase compared to normal body temperature
(37°C) [22, 39], since the solubility of a gas within a liquid (such as blood) decreases with lower
temperature due to physical laws. A review of 16 studies comparing the efficacy of these two
strategies in managing acid-base disturbances in the context of deep hypothermic circulatory
arrest have suggested that the pH-stat strategy should be preferred for the pediatric population
[40–44]. Such a study has not yet been performed in asphyxiated newborns treated with
cooling. In the large randomized controlled trials of therapeutic hypothermia following
asphyxia [9, 10], the pH-stat strategy was used, since it was considered to be the most cautious
approach for maintaining the physiologic partial pressure of carbon dioxide and pH levels.
With this strategy, ventilator settings need to be decreased more aggressively.
5. Conclusions
The respiratory management of asphyxiated newborns treated with hypothermia is complex.
Many factors specifically related to asphyxia and hypothermia must be considered when
dealing with the ventilatory management of these newborns, so to offer them the best possible
level of care. Evidence is currently lacking regarding the best practices to use to optimize
oxygenation and ventilation in these newborns and prevent the development of further brain
injury. Further studies should be performed to determine what is the optimal mode of
ventilation and what are the most optimal values for oxygenation parameters for these
newborns during hypothermia treatment. Until then, the treating team should keep a very
close eye on them to maintain, as much as possible, homeostasis, and to avoid hypoxemia,
hyperventilation, and hypocapnia.
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